Andere Kunden interessierten sich auch für
![Long Acting Injections and Implants]( "Long Acting Injections and Implants")
Long Acting Injections and Implants147,99 €![Cellulose based nanocomposite for transdermal drug delivery system]( "Cellulose based nanocomposite for transdermal drug delivery system")
Cellulose based nanocomposite for transdermal drug delivery system29,99 €![Nanofiber based drug delivery system against Leishmaniasis]( "Nanofiber based drug delivery system against Leishmaniasis")
Nanofiber based drug delivery system against Leishmaniasis29,99 €![Design & Analysis of five level inverter controlled with DVR]( "Design & Analysis of five level inverter controlled with DVR")
Design & Analysis of five level inverter controlled with DVR29,99 €![Modification of Auto Light Controlled System by PLC]( "Modification of Auto Light Controlled System by PLC")
Modification of Auto Light Controlled System by PLC26,99 €![Hand Gesture Controlled Wheelchair]( "Hand Gesture Controlled Wheelchair")
Hand Gesture Controlled Wheelchair32,99 €![Fpga controlled three phase inverter based bldc motor drive]( "Fpga controlled three phase inverter based bldc motor drive")
Fpga controlled three phase inverter based bldc motor drive44,99 €
Osmotic systems, one of the oral dosage form utilize the principles of osmotic pressure for the delivery of drugs. Drug release from these systems is independent of pH and other physiological parameters and it is also possible to modulate the release characteristics by optimizing the properties of drug and system. The aim of present research was to design and optimize the three novel osmotic drug delivery systems viz. Swellable Porous Osmotic System (SPOP), Monolithic Osmotic Tablet System (MOTS) & Controlled Porosity Osmotic System (CPOP) for water soluble and low water soluble drugs and compare principle and methodology of CR design. Extended release formulations of Venlafaxine HCl and Glipizide were developed based on SPOP technology. Extended release formulations of Metoprolol Tartrate and Nifedipine were developed based on MOTS technology. Extended release formulations of Oxybutynin chloride and Atenolol were developed based on CPOP technology. Based on the present work it is clear that extended release formulations of drugs having different solubility profile can be developed using these technologies. The in-vivo pharmacokinetic study in beagle dog confirmed the same.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.